Efficacy of Weight Reduction on Pediatric Nonalcoholic Fatty Liver Disease: Opportunities to Improve Treatment Outcomes Through Pharmacotherapy

Obesity is the single greatest risk factor for nonalcoholic fatty liver disease (NAFLD). Without intervention, most pediatric patients with NAFLD continue to gain excessive weight, making early, effective weight loss intervention key for disease treatment and prevention of NAFLD progression. Unfortu...

Descripción completa

Detalles Bibliográficos
Autores principales: Friesen, Chance S., Hosey-Cojocari, Chelsea, Chan, Sherwin S., Csanaky, Iván L., Wagner, Jonathan B., Sweeney, Brooke R., Friesen, Alec, Fraser, Jason D., Shakhnovich, Valentina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8076784/
https://www.ncbi.nlm.nih.gov/pubmed/33927697
http://dx.doi.org/10.3389/fendo.2021.663351

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8076784/
https://www.ncbi.nlm.nih.gov/pubmed/33927697
http://dx.doi.org/10.3389/fendo.2021.663351

Ejemplares similares